Related Experiment Videos
Hyperlipidemia: a new therapeutic target for diabetic neuropathy
Andrea M Vincent1, Lucy M Hinder, Rodica Pop-Busui
1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. andreav@umich.edu
Abstract:
Emerging data establish dyslipidemia as a significant contributor to the development of diabetic neuropathy. In this review, we discuss how separate metabolic imbalances, including hyperglycemia and hyperlipidemia, converge on mechanisms leading to oxidative stress in dorsal root ganglia (DRG) sensory neurons. We conclude with suggestions for novel therapeutic strategies to prevent or reverse diabetes-induced nerve degeneration.
Related Concept Videos
Diabetic Neuropathy
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Diabetic Retinopathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Nephropathy
Atherosclerosis III: Management